register

News & Trends - Biotechnology

‘Innovation makes a real and measurable difference to people’s lives at their most vulnerable time’, says Noxopharm CEO: National Science Week

Health Industry Hub | August 16, 2023 |

Biotech News: Embarking on the next chapter of our interview series celebrating National Science Week, Dr Gisela Mautner, CEO and Managing Director of Australian biotech company Noxopharm delved into the intersection between innovation and the dynamic healthcare landscape.

At the heart of our conversation was the National Science Week theme, Innovation: Powering Future Industries. Dr Mautner’s articulation of her personal passion for STEM underscored the profound alignment between her dedication and the overarching theme.

“Innovation in the development of new technologies is absolutely central to bridging the gaps that we have in the current healthcare system, to be able to improve patients’ lives. This is why I’m so excited about STEM as it’s a relentless push of current boundaries. I feel it makes a real and measurable difference to people’s lives, and specifically to people’s lives at their most vulnerable time when they’re sick,” she stated.

Turning our attention to recent events, Dr Mautner shared the key highlights from the BIO International Convention. These highlights seamlessly converged with Noxopharm’s pioneering research pursuits, underscoring the organisation’s commitment to steering healthcare innovation toward new horizons.

Anticipating the future, Dr Mautner shared her perspectives on the forthcoming RNA Leaders Congress in Boston. Her observations regarding the conference’s alignment with the National Science Week theme emphasised the enduring impact of innovation as an enabler of progress within healthcare.

In reflecting upon the year so far, Dr Mautner shared a thoughtful evaluation of the accomplishments that resonate most profoundly. Her insights unveil strategic milestones that underscore Noxopharm’s pivotal contribution to shaping the trajectory of innovation in healthcare.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.